Ageing, Obstructive Sleep Apnea (OSA) and obesity are becoming more common in the community. Each is associated with increased heart disease and metabolic disorders. Understanding how androgen dysregulation exacerbates OSA, obesity and ageing and how androgen treatments alter these conditions may lead to reduced cardiometabolic dysfunction and improved health.